-
Cardiac Biomarkers in Epileptic Baboons
2026-08-24
Szabó and colleagues identified prolonged QT and QTcF intervals, together with a nonsignificant reduction in RMSSD, in epileptic baboons from a captive pedigree. The study strengthens the baboon as a translational model for investigating cardiac contributions to epilepsy and SUDEP while illustrating the value and limits of ECG data collected during scalp EEG.
-
Fludarabine: From Mechanism to Translational Strategy
2026-08-24
Fludarabine is more than a cytotoxic benchmark: it is a mechanistically resolved DNA synthesis inhibitor that can connect nucleotide metabolism, replication stress, cell-cycle control, and apoptosis in translational oncology models. This article outlines how to deploy it strategically in leukemia research, multiple myeloma research, and genotype-aware experimental programs without overstating preclinical evidence.
-
Mitochondrial Permeability Transition Pore Assay Kit Guide
2026-08-22
Use the Mitochondrial Permeability Transition Pore Assay Kit to convert mitochondrial pore opening into a cell-resolved fluorescence readout for disease modeling, compound screening, and cell death mechanism research. This guide connects the Calcein AM fluorescent probe workflow with the integrated mitochondrial endpoints used in recent carpal tunnel syndrome research.
-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-08-22
This study identifies Kupffer cell-expressed TMEM16F as a key determinant of host protection during Listeria monocytogenes infection, shifting attention from lymphocytes to liver-resident macrophages. Its findings connect calcium-activated lipid scrambling and plasma-membrane repair with the control of liver inflammation, tissue injury, and metabolic disruption.
-
Marein Restores Mitoxantrone Sensitivity via ABCG2
2026-08-21
The reference study identifies marein, a chalcone-type flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug transporter. By increasing intracellular exposure to ABCG2 substrates, marein restored cancer-cell sensitivity to mitoxantrone, topotecan, and olaparib, highlighting a transporter-focused strategy for investigating multidrug resistance.
-
2D and 3D Radiosensitizer Screening in Cancer Models
2026-08-20
This 2025 Acta Oncologica study provides a systematic comparison of DNA-PKcs, ATR, PARP, and IAP inhibition in matched two-dimensional and extracellular-matrix-based three-dimensional lung cancer models. Its findings show that 2D assays often identify similar radiosensitizers, while 3D cultures add information about matrix-dependent responses that can improve preclinical prioritization.
-
MLN8237 (Alisertib): From Mitosis to Immunity
2026-08-20
MLN8237 (Alisertib) offers a selective pharmacological entry point into Aurora A biology. This thought-leadership analysis connects mitotic control, apoptosis, SAM-dependent chromatin regulation, trained immunity, and translational study design for researchers investigating cancer biology and oncogenesis.
-
Chemotherapy Enhances Neoantigen T Cell Therapy
2026-08-19
Sagie et al. identify a KRAS.G12V-specific T cell receptor, T104, and show that lymphodepleting chemotherapy improves neoantigen-directed tumor killing by increasing immunoproteasome activity and HLA-I presentation. The study provides a mechanistic framework for combining chemotherapy with TCR-T cells, tumor-infiltrating lymphocytes, or T cell engagers while highlighting important translational limitations.
-
Cardamomin Protects Against Ischemic Stroke Oxidative Damage
2026-08-19
This study links the chalcone cardamomin from Amomum villosum Lour. with protection against hydrogen peroxide-induced oxidative injury and permanent cerebral ischemia. Its main contribution is a mechanistic model involving MEK/ERK-mediated NRF2 activation, suppression of oxeiptosis, and reduced parthanatos, supported by complementary cellular and rat stroke experiments.
-
A-1210477 Workflow for MCL-1 Apoptosis
2026-08-18
A-1210477 is a selective MCL-1 inhibitor for dissecting apoptosis dependence in cancer cell models, with strong utility in dose-response, mitochondrial assays, and combination screens. This practical workflow emphasizes stock preparation, mechanistic controls, and troubleshooting for reproducible in vitro cancer research rather than unsupported in vivo translation.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-08-18
Song et al. show that murine norovirus repurposes the membrane-rupture factor NINJ1 to release the viral protein NS1 after caspase-3 cleavage of NS1/2. The study combines CRISPR screening, cell biology, mutagenesis, and mouse infection models to connect unconventional secretion with enteric viral pathogenesis.
-
SkQ1, Apoptosis, and Muscle Atrophy in Ovarian Cancer
2026-08-17
A 2024 bioRxiv preprint used a metastatic ovarian cancer mouse model to separate mitochondrial oxidative stress, apoptosis, necroptosis, and skeletal muscle atrophy across disease stages. SkQ1 reduced mitochondrial hydrogen peroxide emission and caspase-9/3 activity in late-stage disease but did not preserve gastrocnemius muscle mass, challenging a simple causal model of ROS-driven muscle loss.
-
ISRIB (trans-isomer) in ER Stress and Fibrosis
2026-08-17
ISRIB (trans-isomer) offers a practical way to separate upstream eIF2α phosphorylation from downstream translational shutdown in ER stress research. Its strongest use-case is a mechanism-first workflow linking ATF4 translation, HSC activation, ECM production, and stress-induced apoptosis while preserving clear controls for interpretation.
-
Verapamil Targets TXNIP in Osteoporosis
2026-08-16
The reference study presents verapamil as a potential osteoporosis intervention by showing that TXNIP suppression reduces abnormal bone turnover in cellular models and ovariectomized mice. Its combination of human genetic association data, mechanistic experiments, and in vivo imaging provides a preclinical framework for evaluating this repurposing strategy while leaving clinical efficacy and dosing questions unresolved.
-
Z-VAD-FMK in Ferroptosis Research Workflows
2026-08-15
Use Z-VAD-FMK to separate caspase-dependent apoptosis from ferroptosis in high-glucose lens epithelial cell models. This workflow combines apoptosis inhibition, caspase activity measurement, and the reference study’s FerroOrange, ROS, and GSH readouts for more defensible pathway assignments.